Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11912714 Spiropyrrolidine derived antiviral agents

Patent 11912714 was granted and assigned to Enanta Pharmaceuticals on February, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Enanta Pharmaceuticals

0

Current Assignee

Enanta Pharmaceuticals

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Wei Li0

Hui Cao0

Xuri Gao0

Xiaowen Peng0

Ruichao Shen0

Yat Sun Or0

Guoqiang Wang0

Jiajun Zhang0

...

Date of Patent

February 27, 2024

0

Patent Application Number

179835010

Date Filed

November 9, 2022

0

Patent Citations

US Patent 9428739 Norovirus and Sapovirus antigens

0

US Patent 8222288 Small molecule inhibitors of MDM2 and the uses thereof

0

US Patent 8222425 Organic compounds and their uses

0

US Patent 8372802 Fluorinated macrocyclic compounds as hepatitis C virus inhibitors

0

US Patent 9290757 Protease screening methods and proteases identified thereby

0

US Patent 9309284 Macrocyclic and peptidomimetic compounds as broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, caliciviruses and coronaviruses

0

US Patent 11058763 Porcine epidemic diarrhea virus strains and immunogenic compositions therefrom

0

US Patent 11058779 Sirna/nanoparticle formulations for treatment of middle-east respiratory syndrome coronaviral infection

0

...

Patent Primary Examiner

Joseph R Kosack

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11912714 Spiropyrrolidine derived antiviral agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.